A MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, ADD-ON STUDY OF MLR-1023 IN ADULTS WITH UNCONTROLLED TYPE 2 DIABETES ON METFORMIN THERAPY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

DeFronzo, Ralph A

Funded by

MELIOR PHARMACEUTICALS

Research Start Date

01/01/2019

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Bioscience Research Panel